- Filed two patent applications
- Designed Smart mRNAs for detecting breast cancer, pancreatic cancer, acute myeloid leukemia, lung cancer, and Ewing sarcoma
- Lab tests to validate and optimize Smart mRNAs in real cancer cells lines (H2 2024)
- Design and optimize fully functional CancerVax nanoparticles (H1 2025)
